At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
SITC SITE Centers Corp.
Market Closed 06-12 16:00:00 EDT
4.94
-0.07
-1.40%
盘后4.94
+0.000.00%
17:34 EDT
High5.05Low4.89Vol502.75K
Open5.02D1 Closing5.01Amplitude3.19%
Mkt Cap259.16MTradable Cap258.11MTotal Shares52.46M
T/O2.49MT/O Rate0.96%Tradable Shares52.25M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

SITE Centers agrees to sell Pike Outlets Long Beach for USD 50 million cash
Reuters  ·  05-21
SITE Centers agrees to sell Pike Outlets Long Beach for USD 50 million cash
Site Centers shareholders approve director term change at annual meeting
Reuters  ·  05-15
Site Centers shareholders approve director term change at annual meeting
Fate Therapeutics Reports First Quarter 2026 Financial Results and Business Updates
GlobeNewswire  ·  05-13
Fate Therapeutics Reports First Quarter 2026 Financial Results and Business Updates
Shopping centre owner SITE Centers Q1 operating FFO turns negative
Reuters  ·  05-08
Shopping centre owner SITE Centers Q1 operating FFO turns negative
SITE Centers Q1 FY26 operating FFO swings to $1.9 million loss; net income falls to $938,000
Reuters  ·  05-08
SITE Centers Q1 FY26 operating FFO swings to $1.9 million loss; net income falls to $938,000
CytomX Therapeutics Announces Q1 2026 Financial Results and Provides Business Update
GlobeNewswire  ·  05-08
CytomX Therapeutics Announces Q1 2026 Financial Results and Provides Business Update
BRIEF-SITE Centers Q1 Net Income USD 900 Thousand
Reuters  ·  05-08
BRIEF-SITE Centers Q1 Net Income USD 900 Thousand
Site Centers Q1 Ffo per Share USD -0.02
THOMSON REUTERS  ·  05-08
Site Centers Q1 Ffo per Share USD -0.02
Site Centers Q1 Adjusted Ffo per Share USD -0.04
THOMSON REUTERS  ·  05-08
Site Centers Q1 Adjusted Ffo per Share USD -0.04
Site Centers Corp expected to post a share - Earnings Preview
Reuters  ·  05-06
Site Centers Corp expected to post a share - Earnings Preview
BRIEF-Site Centers Announces Sale Of Meadowmont Crossing
Reuters  ·  05-05
BRIEF-Site Centers Announces Sale Of Meadowmont Crossing
Site Centers announces sale of Meadowmont Crossing for $11.1M
TIPRANKS  ·  05-05
Site Centers announces sale of Meadowmont Crossing for $11.1M
Site Centers sells Meadowmont Crossing shopping center for $11.1 million
Reuters  ·  05-05
Site Centers sells Meadowmont Crossing shopping center for $11.1 million
Site Centers Announces Sale of Meadowmont Crossing
THOMSON REUTERS  ·  05-05
Site Centers Announces Sale of Meadowmont Crossing
Molecular Partners publishes Phase 1 MP0317 data in Nature Cancer demonstrating tumor-localized CD40 activation and tumor microenvironment remodeling
GlobeNewswire  ·  05-01
Molecular Partners publishes Phase 1 MP0317 data in Nature Cancer demonstrating tumor-localized CD40 activation and tumor microenvironment remodeling
Site Centers to release first-quarter earnings after market close May 7
Reuters  ·  04-24
Site Centers to release first-quarter earnings after market close May 7
Analysts Offer Insights on Real Estate Companies: SITE Centers (SITC) and Rithm Capital (RITM)
TIPRANKS  ·  04-22
Analysts Offer Insights on Real Estate Companies: SITE Centers (SITC) and Rithm Capital (RITM)
IMUNON Reports 2025 Financial Results and Provides Business Update Highlighting Significant Progress with Pivotal Phase 3 Study
GlobeNewswire  ·  03-31
IMUNON Reports 2025 Financial Results and Provides Business Update Highlighting Significant Progress with Pivotal Phase 3 Study
HOOKIPA Pharma Announces Completion of Sale of Oncology Assets to NeoTrail Therapeutics
GlobeNewswire  ·  03-26
HOOKIPA Pharma Announces Completion of Sale of Oncology Assets to NeoTrail Therapeutics
Press Release: Transgene Continues Progress to Reshape Early-Stage Cancer Treatment through Individualized Neoantigen Therapeutic Vaccines (INTV) Backed by Financial Visibility Until Early 2028
Dow Jones  ·  03-25
Press Release: Transgene Continues Progress to Reshape Early-Stage Cancer Treatment through Individualized Neoantigen Therapeutic Vaccines (INTV) Backed by Financial Visibility Until Early 2028

Introduction

Company Name.
SITE Centers Corp.
Affiliated Markets:
NYSE
Listing Date:
--
Main Business:
SITE Centers is an owner and manager of open-air shopping centers located in suburban, high household income communities. The Company is a self-administered and self-managed REIT operating as a fully integrated real estate company, and is publicly traded on the New York Stock Exchange under the ticker symbol SITC.
Issue price:
--